Australia markets closed

Paragon Care Limited (PGC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3300-0.0100 (-2.94%)
At close: 04:10PM AEST

Paragon Care Limited

Waterman Business Centres
Suite 46 44 Lakeview Drive
Scoresby, VIC 3179
Australia
61 3 8833 7800
https://www.paragoncare.com.au

Sector(s)Healthcare
IndustryMedical Distribution
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Mark Robert Hooper BBus (Acc), C.P.A., CPA, FFTP, M.A.I.C.D., MAICDGroup CEO, MD & Director838.91kN/A1959
Mr. Stephen J. MundayChief Financial Officer323.04kN/A1964
Mr. John Andrew WalstabExec. Director & Exec. GM of Paragon Care Asia307.66kN/A1963
Ms. Melanie Jaye Leydin B.Bus, C.A., CAJoint Company Sec.N/AN/A1973
Ms. Claire Newstead-Sinclair BBus, C.A., CAJoint Company Sec.N/AN/AN/A
Mr. Michael G. RiceGroup Commercial Mang.N/AN/A1976
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides telephony, nurse call, access control, CCTV, cordless, and Wi-Fi products. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. Paragon Care Limited was incorporated in 1994 and is based in Melbourne, Australia.

Corporate governance

Paragon Care Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.